Last update 29 Dec 2024

ODS-2004436

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
18F-ODS2004436, ODS 2004436, ODS-2006405-1
+ [1]
Target
EGFR
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), PET imaging(Positron-emission tomography enhancers)
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication-
Inactive Indication
Lung CancerNon-Small Cell Lung Cancer
Originator Organization
Oncodesign Precision Medicine SA
Active Organization-
Inactive Organization
Oncodesign Precision Medicine SACyclopharm Ltd.Cyclopharm Ltd.
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC26H29ClFN5O4
InChIKeyCUZWIVWWRLVMOQ-ZUGUBGFXSA-N
CAS Registry2130982-18-0

Related

100 Clinical Results associated with ODS-2004436
Login to view more data
100 Translational Medicine associated with ODS-2004436
Login to view more data
100 Patents (Medical) associated with ODS-2004436
Login to view more data
100 Deals associated with ODS-2004436
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lung CancerPhase 1-
Oncodesign Precision Medicine SA
-
Lung CancerPhase 1-
Cyclopharm Ltd.Cyclopharm Ltd.
-
Non-Small Cell Lung CancerPhase 1
FR
Oncodesign Precision Medicine SA
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free